Tag: GILD

Finance

Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Agenus (NASDAQ:AGEN), Merck & Co (NYSE:MRK)

Spirits maker Diageo North America and pharmaceutical giant Pfizer Inc. (NYSE:PFE) have each agreed to pay a $5,000 fine because their lobbyists failed to disclose expenditures for receptions at the 2012 Democratic National Convention, the Office of State Ethics announced. Pfizer Inc. (NYSE:PFE) stock performance was 1.35% in last session and finished the day at $30.08. Traded volume was 25.60million shares in the last session … Continue reading Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Agenus (NASDAQ:AGEN), Merck & Co (NYSE:MRK)

Kristen Barton
business, Finance

Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) stock performance was … Continue reading Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

Adam Keintzel
Finance

Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) stock performance was … Continue reading Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

Jason Knox
Finance

Hot Biotech Movers: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Insmed Incorporated (NASDAQ:INSM), Gilead Sciences, Inc. (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) saw a significant decrease in short interest during the month of May. As of May 30th, there was short interest totalling 8,284,614 shares, a decrease of 15.5% from the May 15th total of 9,799,100 shares. Several analysts have recently commented on the stock. Analysts at Roth Capital downgraded shares of Chelsea Therapeutics International from a “buy” rating to a “neutral” … Continue reading Hot Biotech Movers: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Insmed Incorporated (NASDAQ:INSM), Gilead Sciences, Inc. (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Kristen Barton
Finance

Biotech Movers: Geron Corporation (NASDAQ:GERN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Gilead Sciences (NASDAQ:GILD)

Geron Corporation (NASDAQ:GERN) on June 12 announced that the U.S. Food and Drug Administration (FDA) has removed the partial clinical hold on the investigator-sponsored clinical trial of imetelstat in myelofibrosis (Myelofibrosis IST). The partial clinical hold was placed in March 2014 due to a safety signal of hepatotoxicity that was identified in clinical trials of imetelstat. Geron Corporation (NASDAQ:GERN) stock performance was 4.01% in last … Continue reading Biotech Movers: Geron Corporation (NASDAQ:GERN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Gilead Sciences (NASDAQ:GILD)

John Bellich
Finance

Hot Watch List: Apple Inc. (NASDAQ:AAPL), Twitter Inc (NYSE:TWTR), Gilead Sciences, Inc. (NASDAQ:GILD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Apple Inc. (NASDAQ:AAPL)’s resurgent stock may have as much to do with financial engineering as the company’s technological wizardry. Monday marked Apple Inc. (NASDAQ:AAPL)’s first stock split in nine years, a move designed to make it more affordable to buy shares of the iPhone and iPad maker. Apple Inc. (NASDAQ:AAPL) stock performance was 1.60% in last session and finished the day at $93.70. Traded volume … Continue reading Hot Watch List: Apple Inc. (NASDAQ:AAPL), Twitter Inc (NYSE:TWTR), Gilead Sciences, Inc. (NASDAQ:GILD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Jayne Crisman